European evidenced-based consensus on reproduction in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 4, Issue 5, 2010, Pages 493-510

  van der Woude, C Janneke ^a   Kolacek, Sanja ^b   Dotan, Iris ^c   Øresland, Tom ^d   Vermeire, Séverine ^e   Munkholm, Pia ^f   Mahadevan, Uma ^g   Mackillop, Lucy ^h   Dignass, Axel ⁱ  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Croatia   (Croatia)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h JOHN RADCLIFFE HOSPITAL   (United Kingdom)

ⁱ GOETHE UNIVERSITY   (Germany)

Author keywords

Crohn's disease; Inflammatory bowel disease; Lactation; Pregnancy; Reproduction; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BCG VACCINE; BETAMETHASONE; BUDESONIDE; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; ORAL CONTRACEPTIVE AGENT; ORAL POLIOMYELITIS VACCINE; PREDNISOLONE; PREDNISONE; ROTAVIRUS VACCINE; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; TIOGUANINE; UNINDEXED DRUG; WART VIRUS VACCINE;

ABDOMINAL SURGERY; ABORTION; ADRENAL SUPPRESSION; ADVERSE OUTCOME; CANCER SCREENING; CENTRAL NERVOUS SYSTEM MALFORMATION; CESAREAN SECTION; CHROMOSOME ABERRATION; CLEFT LIP; CLEFT PALATE; CLINICAL PRACTICE; CONGENITAL MALFORMATION; CONSENSUS DEVELOPMENT; CRANIOFACIAL MALFORMATION; CROHN DISEASE; DELIVERY; DISEASE ACTIVITY; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG SAFETY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; EUROPE; EVIDENCE BASED MEDICINE; FERTILITY; FETUS MALFORMATION; FETUS WASTAGE; FOLIC ACID DEFICIENCY; GASTROINTESTINAL ENDOSCOPY; GROWTH RETARDATION; HEALTH PROGRAM; HUMAN; LACTATION; LIMB MALFORMATION; LOW BIRTH WEIGHT; MATERNAL DISEASE; NONHUMAN; ORAL CONTRACEPTION; OUTCOMES RESEARCH; POLIOMYELITIS; PRACTICE GUIDELINE; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RELAPSE; REPRODUCTION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ROTAVIRUS INFECTION; SEDATION; SEX DIFFERENCE; SEXUALITY; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TUBERCULOSIS; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; VACCINATION; VENOUS THROMBOEMBOLISM; VIRUS INFECTION; WART VIRUS;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; BREAST FEEDING; CHILD; COLITIS, ULCERATIVE; CONTRACEPTIVES, ORAL; CROHN DISEASE; DRUG TOXICITY; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FERTILITY; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; LACTATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 77958154477     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.07.004     Document Type: Review

References (228)

1. Mountifield R., Bampton P., Prosser R., Muller K., Andrews J.M. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009, 15:720-725.
2. Zelinkova Z., Baars J., Markus T., Looman C.W., Kuipers E.J., Van Der Woude C.J. Female perception of the quality of life differs from male inflammatory bowel disease patients. Gut 2007, 39(Suppl No I):A145.
3. Baird D.D., Narendranathan M., Sandler R.S. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990, 99:987-994.
4. Marri S.R., Ahn C., Buchman A.L. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:591-599.
5. Anonymous, centre for evidence based medicine, Oxford. Levels of evidence and grades of recommendation. Updated 5-7-2010. http://www.cebm.net.
6. Boothby L.A., Doering P.L. FDA labeling system for drugs in pregnancy. Ann Pharmacother 2001, 35:1485-1489.
7. Mayberry J.F., Weterman I.T. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986, 27:821-825.
8. Hudson M., Flett G., Sinclair T.S., Brunt P.W., Templeton A., Mowat N.A. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997, 58:229-237.
9. Ørding Olsen K., Juul S., Berndtsson I., Oresland T., Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002, 122:15-19.
10. Levi A.J., Fisher A.M., Hughes L., Hendry W.F. Male infertility due to sulphasalazine. Lancet 1979, 2:276-278.
11. Birnie G.G., McLeod T.I., Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 1981, 22:452-455.
12. O'Morain C., Smethurst P., Dore C.J., Levi A.J. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984, 25:1078-1084.
13. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 1979, 31:538-540.
14. Dejaco C., Mittermaier C., Reinisch W., Gasche C., Waldhoer T., Strohmer H., et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001, 121:1048-1053.
15. Sussman A., Leonard J.M. Psoriasis, methotrexate, and oligopsermia. Arch Dermatol 1980, 116:215-217.
16. Mahadevan U., Terdiman J.P., Aron J.A., Jacobsohn S., Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:395-399.
17. Katz J.A., Antoni C., Keenan G.F., Smith D.E., Jacobs S.J., Lichtenstein G.R. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004, 99:2385-2392.
18. Tiainen J., Matikainen M., Hiltunen K.M. Ileal J-pouch-anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol 1999, 34:185-188.
19. Damgaard B., Wettergren A., Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis Colon Rectum 1995, 38:286-289.
20. Johnson E., Carlsen E., Nazir M., Nygaard K. Morbidity and functional outcome after restorative proctocolectomy for ulcerative colitis. Eur J Surg 2001, 167:40-45.
21. Davies R.J., O'Connor B.I., Victor C., MacRae H.M., Cohen Z., McLeod R.S. A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis. Dis Colon Rectum 2008, 51:1032-1035.
22. Lepistö A., Sarna S., Tiitinen A., Järvinen H.J. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg 2007, 94:478-482.
23. Gorgun E., Remzi F.H., Goldberg J.M., Thornton J., Bast J., Hull T.L., et al. Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery 2004, 136:795-803.
24. Ørding Olsen K., Juul S., Berndtsson I., Oresland T., Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002, 122:15-19.
25. Johnson P., Richard C., Ravid A., Spencer L., Pinto E., Hanna M., et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004, 47:1119-1126.
26. Olsen K.O., Joelsson M., Laurberg S., Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999, 86:493-495.
27. Cornish J.A., Tan E., Teare J., Teoh T.G., Rai R., Darzi A.W., et al. The effect of restorative procolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007, 50:1128-1138.
28. Waljee A., Waljee J., Morris A.M., Higgins P.D.R. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006, 55:1575-1580.
29. Oresland T., Palmblad S., Ellström M., Berndtsson I., Crona N., Hultén L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis 1994, 9:77-81.
30. Asztély M., Palmblad S., Wikland M., Hultén L. Radiological study of changes in the pelvis in women following proctectomy. Int J Colorectal Dis 1991, 6:103-107.
31. Van Horn C., Barrett P. Pregnancy, delivery, and postpartum experiences of fifty-four women with ostomies. J Wound Ostomy Continence Nurs 1997, 24:151-162.
32. Korelitz B.I. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998, 27:213-224.
33. Reddy D., Murphy S.J., Kane S.V., Present D.H., Kornbluth A.A. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008, 103:1203-1209.
34. Bortoli A., Saibeni S., Tatarella M., Prada A., Beretta L., Rivolta R., et al. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 2007, 22:542-549.
35. Buyon J.P. The effects of pregnancy on autoimmune diseases. J Leukoc Biol 1998, 63:281-287.
36. Fedorkow D.M., Persaud D., Nimrod C.A. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989, 160:998-1001.
37. Mogadam M., Dobbins W.O., Korelitz B.I., Ahmed S.W. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981, 80:72-76.
38. Mahadevan U., Sandborn W.J., Li D., Hakimian S., Kane S. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from northern California. Gastroenterology 2007, 133:1106-1112.
39. Cornish J., Tan E., Teare J., Teoh T.G., Rai R., Clark S.K., et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007, 56:830-837.
40. Castiglione F., Pignata S., Morace F., Sarubbi A., Baratta M.A., D'Agostino L., et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996, 28:199-204.
41. Riis L., Vind I., Politi P., Wolters F., Vermeire S., Tsianos E., et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006, 101:1539-1545.
42. Nwokolo C.U., Tan W.C., Andrews H.A., Allan R.N. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut 1994, 35:220-223.
43. Alstead E.M. Inflammatory bowel disease in pregnancy. Postgrad Med J 2002, 78:23-26.
44. Ilnyckyji A., Blanchard J.F., Rawsthorne P., Bernstein C.N. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 1999, 94:3274-3278.
45. Brandt L.J., Estabrook S.G., Reinus J.F. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol 1995, 90:1918-1922.
46. Hahnloser D., Pemberton J.H., Wolff B.G., Larson D., Harrington J., Farouk R., et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long term consequences and outcomes. Dis Colon Rectum 2004, 47:1127-1135.
47. Ramalingam T., Box B., Mortensen N.M. Pregnancy delivery and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2003, 46:1292.
48. Remzi F.H., Gorgun E., Bast J., Schroeder T., Hammel J., Philipson E., et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005, 48:1691-1699.
49. Polle S.W., Vlug M.S., Slors J.F., Zwinderman A.H., van der Hoop A.G., Cuesta M.A., et al. Effect of vaginal delivery on long term pouch function. Br J Surg 2006, 93:1394-1401.
50. Nicholl M.C., Thompson J.M., Cocks P.S. Stomas and pregnancy. Aust N Z J Obstet Gynaecol 1993, 33:322-324.
51. Lepito A., Sarna S., Tiitinen A., Jarvinen H.J. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg 2007, 94:478-482.
52. Ravid A., Richard C.S., Spencer L.M., O'Connor B.I., Kennedy E.D., MacRae H.M., et al. Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2002, 45:1283-1288.
53. Ong J.P., Edwards G.J., Allison M.C. Mode of delivery and risk of feacal incontinence in women with or without inflammatory bowel disease: questionnaire survey. Inflamm Bowel Dis 2007, 13:1391-1394.
54. Mogadam M., Korelitz B.I., Ahmed S.W., Dobbins W.O., Baiocco P.J. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol 1981, 75:265-269.
55. Moffatt D.C., Ilnyckyj A., Bernstein C.N. A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the postpartum period. Am J Gastroenterol 2009, 104:2517-2523.
56. Scott H.J., McLeod R.S., Blair J., O'Connor B., Cohen Z. Ileal pouch-anal anastomosis: pregnancy, delivery and pouch function. Int J Colorectal Dis 1996, 11:84-87.
57. Yang H., McElree C., Roth M.P., Shanahan F., Targan S.R., Rotter J.I. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993, 34:517-524.
58. Orholm M., Munkholm P., Langholz E., Nielsen O.H., Sørensen T.I., Binder V. Familial occurrence of inflammatory bowel disease. NEJM 1991, 324:84-88.
59. Peeters M., Nevens H., Baert F., Hiele M., de Meyer A.M., Vlietinck R., et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996, 111:597-603.
60. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996, 39:690-697.
61. Laharie D., Debeugny S., Peeters M., Van Gossum A., Gower-Rousseau C., Bélaïche J., et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001, 120:816-819.
62. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
63. Bengston M.B., Solvberg I.C., Aamodt G., Jahnsen J., Moum B. Relationships between inflammatory bowel disease and perinatalfactors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis 2010, 16:847-855. IBSEN study group.
64. Stephansson O., Larsson H., Pedersen L., Kieler H., Granath F., Ludvigsson J.F., et al. Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 2010, 8:509-515. Epub 2010 Mar 2.
65. Bush M.C., Patel S., Lapinski R.H., et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004, 15:237-241.
66. Nguyen G.C., Boudreau H., Harris M., Maxwell C.V. Outcomes of obstetric hospitalization among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009, 7:329-334.
67. Nørgård B., Hundborg H.H., Jacobsen B.A., Nielsen G.L., Fonager K. Disease activity in pregnant women with Crohn's Disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007, 102:1947-1954.
68. Dominitz J.A., Young J.C., Boyko E.J. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002, 97:641-648.
69. Nørgård B., Puho E., Pedersen L., Czeizel A.E., Sørensen H.T. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol 2003, 98:2006-2010.
70. Mahadevan U. Pregnancy and inflammatory bowel disease. Med Clin N Am 2010, 94:53-73.
71. Mahadevan U., Kane S.V., Church J.A. The effect of maternal peripartum infliximab use on neonatal immune response. Gastroenterology 2008, 134(Suppl1):A69.
72. Kaine J.L., Kivitz A.J., Birbara C., et al. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007, 4:72-79.
73. Cheent K., Nolan J., Shariq S., Kiho L., Pal A., Arnold J. Case report: fatal case of disseminated BCG infection in an infant botn to a mother taking infliximab for Crohn's disease. J Crohn's Colitis 2010, 4:603-605. (this issue).
74. Kane S.V., Acquah L.A. Placental transport of immunoglobulins: a clinical review for gastroenterologist who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009, 104:228-3.
75. Papa A., Mocci G., Bomizzi M., Felice C., Andrisani G., De Vitis I., et al. Use of infliximab in particular clinical settings: management based on current evidence. Am J Gastroenterol 2009, 104:1575-1586.
76. Hanan I.M. Inflammatory bowel disease in the pregnant woman. Compr Ther 1998, 24:409-414.
77. Nielsen O.H., Andreasson B., Bondesen S., Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983, 18:735-742.
78. Nielsen O.H., Andreasson B., Bondesen S., Jacobsen O., Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984, 19:724-732.
79. Miller J.P. Inflammatory bowel disease in pregnancy: a review. J R Soc Med 1986, 79:221-225.
80. Khosla R., Willoughby C.P., Jewell D.P. Crohn's disease and pregnancy. Gut 1984, 25:52-56.
81. Willoughby C.P., Truelove S.C. Ulcerative colitis and pregnancy. Gut 1980, 21:469-474.
82. Woolfson K., Cohen Z., McLeod R.S. Crohn's disease and pregnancy. Dis Colon Rectum 1990, 33:869-873.
83. Beniada A., Benoist G., Maurel J., Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Reprod 2005, 34:581-588.
84. Baiocco P.J., Korelitz B.I. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984, 6:211-216.
85. Mahadevan U., Kane S. American Gastroenterology Association Institute technical review on the use of gastrointestinal medication in pregnancy. Gastroenterology 2006, 131:282-311.
86. Nørgård B., Fonager K., Pedersen L., Jacobsen B.A., Sørensen H.T. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003, 52:243-245.
87. Nørgård B., Pedersen L., Christensen L.A., Sorensen H.T. Therapeutic drug use in women with Crohn's Disease and birth outcomes; A Danish Nationalwide Cohort Study. Am J Clin Nutr 2007, 102:1406-1413.
88. Mahadevan U., Corley D. Aminosalicylate (ASA) use during pregnancy is not associated with increased adverse events or congenital malformations in women with inflammatory bowel disease. Gastroenterology 2006, 130(Suppl2):A40. (abstract).
89. Nørgård B., Czeizel A.E., Rockenbauer M., Olsen J., Sørensen H.T. Population-based case control study of the safety of sulfasalazin during pregnancy. Aliment Pharmacol Ther 2001, 15:483-486.
90. Rahimi R., Nikfar S., Rezaie A., Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 2008, 25:271-275.
91. Moffat D.C., Bernstein C.N. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium. Best Pract Res Clin Gastroenterol 2007, 21:835-847.
92. Park-Wyllie L., Mazzotta P., Pastuszak A., Moretti M.E., Beique L., Hunnisett L., et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000, 62:385-392.
93. Carmichael S.L., Shaw G.M., Ma C., Werler M.M., Rasmussen S.A., Lammer E.J. National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007, 197:585. e1-e7.
94. Gur C., Diav-Citrin O., Shechtman S., Arnon J., Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004, 18:93-101.
95. Homar V., Grosek S., Battelino T. High-dose methylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her neonate. Neonatology 2008, 94:306-309.
96. Beaulieu D.B., Ananthakrishnan A.N., Issa M., Rosenbaum L., Skaros S., Newcomer J.R., et al. Budesonide induction and mainenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis 2009, 15:25-28.
97. De Boer N.K., Jarbandhan S.V., de Graaf P., Mulder C.J., van Elburg R.M., van Bodegraven A.A. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006, 101:1390-1392.
98. Jharap B., De Boer N.K.H., Van Der Woude J.C., Hommes D.W., Stokkers P., De Jong D.J., et al. Thiopurine metabolites measurements during pregnancy in mother and child. Gut 2008, 57:A253.
99. Cleary B.J., Kallen B. Early pregnancy azathioprine use and pregnancy outcome. Birth Defects Res 2009, 85:647-654.
100. Goldstein L.H., Dolinsky G., Greenberg R., Schaefer C., Cohen-Kerem R., Diav-Citrin O., et al. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res 2007, 79:696-701.
101. Cassina M., Fabris L., Okolicsanyi L., Gervasi M.T., Memmo A., Tiboni G.M., et al. Therapy of inflammatory bowel disease in pregnancy and lactation. Expert Opin Drug Saf 2009, 8:695-707.
102. Francella A., Dyan A., Bodian C., Rubin P., Chapman M., Present D.H. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003, 124:9-17.
103. Langagergaard V., Pedersen L., Gislum M., Nørgard B., Sørensen H.T. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study. Aliment Pharmacol Ther 2007, 25:73-81.
104. de Boer N.K., Van Elburg R.M., Wilhelm A.J., Remmink A.J., Van Vugt J.M., Mulder C.J., et al. 6-thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child. Scand J Gastroenterol 2005, 40:1374-1377.
105. Bar-Oz B., Hackman R., Einarson T., Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001, 71:1051-1055.
106. Jain A.B., Reyes J., Marcos A., Mazariegos G., Eghtesad B., Fontes P.A., et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single centre's experience update at 13years. Transplantation 2003, 76:827-832.
107. Branche J., Cortot A., Bourreille A., Coffin B., de Vos M., de Saussure P., et al. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis 2009, 15:1044-1048.
108. Baumgart D.C., Sturm A., Wiedenmann B., e Dignass A.U. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut 2005, 54:1822-1823.
109. Dara P., Slater L., Armenrhout S. Succesful pregnancy during chemotherapy for acute leukemia. Cancer 1981, 47:845-846.
110. Kozlowski R.D., Steinbrunner J.V., MacKenzie A.H., Clough J.D., Wilke W.S., Segal A.M. Outcome of first trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990, 88:589-592.
111. Smithells R.W., Newman C.G. Recognition of thalidomide defects. J Med Genet 1992, 29:716-723.
112. Vasiliauskas E.A., Church J.A., Silverman N., Barry M., Targan S.R., Dubinsky M.C. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006, 4:1255-1258.
113. Mahadevan U., Terdiman J., Church J., Vasiliauskas E., Gitis A., Dubinsky M.C. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterol 2007, 132(Suppl 2):A144.
114. Lichtenstein G., Cohen R., Feagan B., Sandborn W., Salzberg B., Chen D., et al. Safety of infliximab in Crohn's disease: data from the 5000-patient TREAT Registry. Gastroenterol 2004, 126(Suppl 4):A54.
115. Vesga L., Terdiman J.P., Mahadevan U. Adalimumab use in pregnancy. Gut 2005, 54:890.
116. Miskin D.S., van Denise W., Becker J.M., Farraye F.A. Succesful use of adalimumab for Crohn's disease in pregnancy. Inflamm Bowel Dis 2006, 12:827-828.
117. Coburn L.A., Wise P.E., Schwartz D.E. The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Dig Dis Sci 2006, 51:2045-2047.
118. Winger E.E., Reed J.L. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008, 60:8-16.
119. Nesbitt A.B.D.S.S., Foulkes R. Placental transfer and accumulation in milk of the anti-TNF antibody TN3 in rats: immunoglobulin G1 versus PEGylated Fab. Am J Gastroenterol 2006, 119. Abstract.
120. Mahadevan U., Abreu M.T. Certolizumab use in pregnancy: low levels detected in cord blood. Gastroenterol 2007, 132:A-144.
121. Piper J.M., Mitchel E.F., Ray W.A. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993, 82:348-352.
122. Schwebke J.R. Metronidazole: utilization in the obstetric and gynecologic patient. Sex Transm Dis 1995, 22:370-376.
123. Berkovitch M., Pastuszak A., Gazarian M., Lewis M., Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994, 84:535-538.
124. Linseman D.A., Hampton L.A., Branstetter D.G. Quinolone induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995, 28:59-64.
125. Hay G., Clausen T., Whitelaw A., Trygg K., Johnston C., Henriksen T., et al. Maternal folate and cobalamin status predicts vitamin status in newborns and 6-month-old infants. J. Nutr. 2010 January 13, 140:557-564.
126. Czeizel A.E., Dudas I., Metneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 1994, 255:131-139.
127. Czeizel A.E., Toth M., Rockenbauer M. Population-based case-control study of folic acid supplementation during pregnancy. Teratology 1996, 53:345-351.
128. Morris J.K., Wald N.J. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. J Med Screen 2007, 14:55-59.
129. Blencowe H., Cousens S., Modell B., Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39(Supplement 1):i110-i121.
130. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24:1507-1523.
131. Kovacs C.S. Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr 2008, 88:520S-528S.
132. Hill J., Clark A., Scott N.A. Surgical treatment of acute manifestations of Crohn's disease during pregnancy. J R Soc Med 1997, 90:64-66.
133. Kane S.V. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am 2003, 32:323-340.
134. Visser B.C., Glasgow R.E., Mulvihill K.K., Mulvihill S.J. Safety and timing of nonobstetric abdominal surgery in pregnancy. Dig Surg 2001, 18:409-417.
135. Kane S., Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005, 100:102-105.
136. Esbjorner E., Jarnerot G., Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 1987, 76:137-142.
137. Diav-Citrin O., Park Y.H., Veerasuntharam G., Polachek H., Bologa M., Pastuszak A., et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998, 114:23-28.
138. Habal F.M., Hui G., Greenberg G.R. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 1993, 105:1057-1060.
139. Marteau P. Foetal outcome in women with IBD treated during pregnancy wit oral mesalazine microgranules. Aliment Pharmacol Ther 1998, 12:1101-1108.
140. Heisterberg L. Blood and milk concentration of metronidazole in mothers and infants. J Perinat Med 1983, 11:114-120.
141. Gardner D.K. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast fed infant. Clin Pharm 1992, 11:352-354.
142. Beitins I.Z., Bayard F., Ances I.G., Kowarski A., Migeon C.J. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972, 81:936-945.
143. Ost L., Wettrell G., Bjorkhem I., Björkhem I., Rane A. Prednisolone excretion in human milk. J Pediatr 1985, 106:1008-1011.
144. Christensen L.A., Dahlerup J.F., Nielsen M.J., Fallingborg J.F., Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008, 28:1209-1213.
145. Zelinkova Z., De Boer I.P., Van Dijke M.J., Kuipers E.J., Van Der Woude C.J. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2009, 30:90-91.
146. Gardiner S.J., Gearry B.B., Roberts R.L., Zhang M., Barclat M.L., Begg E.J. Exposure to thiopurines drugs through breast milk is low based on metabolite concentrations in mother infant pairs. Br J Clin Pharmacol 2006, 62:453-456.
147. Moretti M.E., Verjee Z., Ito S., Koren G. Breast feeding during maternal use of azathioprine. Ann Pharmacother 2006, 40:2269-2272.
148. Schwab M., Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet 2001, 40:723-751.
149. Gardiner S.J., Begg E.J. Breastfeeding during tacrolimus therapy. Obstet Gynecol 2006, 107:453-455.
150. Moretti M.E., Sgro M., Johnson D.W., Sauve R.S., Woolgar M.J., Taddio A., et al. Cyclosporin excretion into breast milk. Transplantation 2003, 75:2144-2146.
151. Kane S., Ford J., Cohen R., Wagner C. Absence of infliximab in infants and breast milk form nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009, 43:613-616.
152. Stengel J.Z., Arnold H.L. Is infliximab safe to use while breastfeeding?. World J Gastroenterol 2008, 14:3085-3087.
153. Ben-Horin S., Yavzori M., Katz L., Picard O., Fudim E., Chowers Y., et al. Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol Hepatol 2010, 8:475-476.
154. Moody G., Probert C.S., Srivastava E.M., Rhodes J., Mayberry J.F. Sexual dysfunction amongst women with Crohn's disease: a hidden problem. Digestion 1992, 52:179-183.
155. Moody G.A., Mayberry J.F. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993, 54:256-260.
156. Weber A.M., Ziegler C., Belinson J.L., Mitchinson A.R., Widrich T., Fazio V. Gynecologic history of women with inflammatory bowel disease. Obstet Gynaecol 1995, 86:843-847.
157. Fuller-Thomson E., Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2008, 12:697-707.
158. Timmer A., Bauer A., Dignass A., Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 2007, 5:87-94.
159. Muller K., Prosser R., Bampton P., Mountifield R., Andrews J.M. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis 2010 Aug E-pub, 16:657-663.
160. Cornish J.A., Tan E., Teare J., Teoh T.G., Rai R., Darzi A.W., et al. The effect of restorative procolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007, 50:1128-1138.
161. Timmer A., Bauer A., Kemptner D., Takses A., Ott C., Fürst A. Determinants of male sexual function in inflammatory bowel disease: a survey-based cross-sectional analysis in 280 men. Inflamm Bowel Dis 2007, 13:1236-1243.
162. Larson D.W., Davies M.M., Dozoiz E.J., Cima R.R., Piotrowica K., Anderson K., et al. Sexual function, body image and quality of life after laparoscopic and open ileal pouch-anal anastomosis. Dis Colon Rectum 2008, 51:392-396.
163. Davies R.J., O'Connor B.I., Victor C., MacRae H.M., Cohen Z., McLeod R.S. A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis. Dis Colon Rectum 2008, 51:1032-1035.
164. Hueting W.E., Gooszen H.G., Laarhoven C.J.H.M. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a meta-analysis and a questionnaire survey. Int J Colorectal Dis 2004, 19:215-218.
165. Berndtsson I., Oresland T., Hulten L. Sexuality in patients with ulcerative colitis before and after restorative procolectomy: a prospective study. Scand J Gastroenterol 2004, 4:374-379.
166. World health organization (WHO) Selected practice recommendations for contraceptive use 2002, WHO, Geneva.
167. Cosnes J., Carbonnel F., Carrat F., Beaugerie L., Gendre J.P. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 1999, 48:218-222.
168. Lashner B.A., Kane S.V., Hanauer S.B. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study. Gastroenterology 1989, 97:1442-1447.
169. Lashner B.A., Kane S.V., Hanauer S.B. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology 1990, 99:1032-1036.
170. Cornish J.A., Tan E., Simillis C., Clark S.K., Teare J., Tekkis P.P. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008, 103:2394-2400.
171. Wakefield A.J., Sawyerr A.M., Hudson M., Dhillon A.P., Pounder R.E. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991, 36:1147-1150.
172. van Vliet H.A., Bertina R.M., Dahm A.E., Rosendaal F.R., Rosing J., Sandset P.M., et al. Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor. Thromb Haemost 2008, 6:346-351.
173. Bloemenkamp K.W., Rosendaal F.R., Helmerhorst F.M., Koster T., Bertina R.M., Vandenbroucke J.P. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Thromb Haemost 1998, 80:382-387.
174. Kluft C., Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997, 78:315-326.
175. Winkler U.H. Blood coagulation and oral contraceptives. A critical review. Contraception 1998, 57:203-209.
176. Rosendaal F.R., Helmerhorst F.M., Vandenbroucke J.P. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002, 22:201-210.
177. Blickstein D., Blickstein I. Oral contraception and thrombophilia. Curr Opin Obstet Gynecol 2007, 19:370-376.
178. Curtis K.M., Chrisman C.E., Peterson H.B. Contraception for women in selected circumstances. Obstet Gynecol 2002, 99:1100-1112.
179. Practice Committee of the American Society of Reproductive Medicine Hormonal contraception: recent advances and controversies. Fertil Steril 2006, 86(5 Suppl):S229-S235.
180. Mohllajee A.P., Curtis K.M., Martins S.L., Peterson H.B. Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review. Contraception 2006, 73:166-178.
181. Bernstein C.N., Blanchard J.F., Houston D.S., Wajda A. The incidence of deep venous trombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.
182. Heit J.A., Kobbervig C.E., James A.H., Petterson T.M., Bailey K.R., Melton L.J. Trends in the incidence of venous thromboembolism during pregnancy or postpartum:a 30-year population-based study. Ann Intern Med 2005, 143:697-706.
183. Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The seventh report of the confidential enquiries into maternal deaths in the United Kingdom, 2007.
184. Pomp E.R., Lenselink A.M., Rosendaal F.R., Doggen C.J. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008, 6:632-637.
185. Novacek G., Welterman A., Sobala A., Tilg H., Petritsch W., Reinisch W., et al. Inflammatory bowel disease is a risk factor for recurrent venous tromboembolism. Gastroenterology 2010 June 12, epub.
186. Nguyen G.C., Boudreau H., Harris M.L., Maxwell C.V. Outcomes of obstretic hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009, 7:329-334.
187. National Clinical Guideline Centre - Acute and chronic conditions. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. London: NCGCACC at the Royal College of Surgeons of England 2010.
188. Greer I.A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005, 15:401-407.
189. Royal College of Obstetricians and Gynaecologists. Thromboembolic disease in pregnancy and the puerperium: acute management. Green-top guideline no. 37. London: RCOG; 2009.
190. Cordiner J.W., Sharp F., Briggs J.D. Cervical intraepithelial neoplasia in immunosuppressed women after renal transplantation. Scott Med J 1980, 25:275-277.
191. Kay S., Frable W.J., Hume D.M. Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer 1970, 26:1048-1052.
192. Wright T.C., Ellerbrock T.V., Chiasson M.A., Van Devanter N., Sun X.W. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994, 84:591-597.
193. Beaufieu D., Tenner V., Venkatesan T. Abnormal Pap smear, cervical dysplasia and immunomodulator treatment in women with inflammatory bowel disease. Gastroenterology 2006, 130(suppl):A17.
194. Hutfless S., Fireman B., Kane S., Herrinton L.J. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2008, 28:598-605.
195. Bhatia J., Bratcher J., Korelitz B., Vakher K., Mannor S., Shevchuk M., et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol 2006, 12:6167-6171.
196. Kane S.V., Khatibi B., Reddy D. Use of immunosuppressants results in a higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008, 103:631-636.
197. Marehbian J., Arrighi H.M., Hass S., Tian H., Sandborn W.J., et al. Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. Am J Gastroenterol 2009, 104:2524-2533.
198. Lees C.W., Critchley J., Chee N., Beez T., Gailer R.E., Williams A.R., et al. Lack of association between cervical dysplasia and IBD: a large case-controlled study. Inflamm Bowel Dis 2009, 15:1621-1629.
199. Singh H., Demers A.A., Nugent Z., e Mahmud S.M., Kliewer E.V., Bernstein C.N. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology 2009, 136:451-458.
200. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56:1-24. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).
201. Rahier J.F., Ben-Horin S., Chowers Y., Conlon C., De Munter P., D'Haens G., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. JCC 2009, 3:47-91.
202. Brent R.L. The effect of embryonic and fetal exposure to X-raymicrowaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 1989, 16:347-368.
203. Brent R.L. Radiation teratogenesis. Teratology 1980, 21:281-298.
204. Tamir I.L., Bomghard F.S., Klein S.R. Acute appendicitis in the pregnant patient. Am J Surg 1990, 160:571-576.
205. Kammerer W.S. Non-obstetric surgery during pregnancy. Med Clin North Am 1979, 63:1157-1164.
206. Cappell M.S. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 2003, 32:123-179.
207. Cappell M.S., Colon V., Sidhom O.A. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome and with comparison to control groups. Am J Gastroenterol 1996, 91:348-354.
208. Quan W.L., Chia C.K., Yim H.B. Safety of endoscopical procedures during pregnancy. Singapore Med J 2006, 47:525-528.
209. Cappell M.S., Sidhom O., Colon V. A study at ten medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996, 41:2353-2360.
210. Jamidar P.A., Beck G.J., Hoffman B.J., Lehman G.A., Hawes R.H., Agrawal R.M., et al. Endoscopic retrograde cholangiopancreatography in pregnancy. Am J Gastroenterol 1995, 90:1263-1276.
211. Tham T.C., Vandervoort J., Wong R.C., Montes H., Roston A.D., Slivka A., et al. Safety of ERCP during pregnancy. Am J Gastroenterol 2003, 987:308-311.
212. Bani Hani M.N., Bani-Hani K.E., Rashdan A., AlWaqfi N.R., Heis H.A., Al-Manasra A.R. Safety of endoscopic retrograde cholangiopancreatography during pregnancy. ANZ J Surg 2009, 79:23-26.
213. Tang S.J., Mayo M.J., Rodriguez-Frias E., Armstrong L., Tang L., Sreenarasimhaiah J., et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc 2009, 69:453-461.
214. Tang S.J., Rodriguez-Frias E., Singh S., Mayo M.J., Jazrawi S.F., Sreenarasimhaiah J., et al. Acute pancreatitis during pregnancy. Clin Gastroenterol Hepatol 2010, 8:85-90.
215. Samara E.T., Stratakis J., Enele Melono J.M., Mouzas I.A., Perisinakis K., Damilakis J. Therapeutic ERPC and pregnancy: is the radiation risk for the conceptus trivial?. Gastrointest Endoosc 2009, 69:824-831.
216. Akcakaya A., Ozkan O.V., Okan I., Kocaman O., Sahin M. Endoscoptic retrograde cholangiopancreatography during pregnancy without radiation. World J Gastoenterol 2009, 15(3):649-652.
217. Morrison J.C., Boyd M., Friedman B.I., Bucovaz E.T., Whybrew W.D., Koury D.N., et al. The effects of Renografin-60 on the fetal thyroid. Obstet Gynecol 1973, 42:99-103.
218. Nardulli G., Limongi F., Sue G., Zapata L., Bompart I. Use of polyethylene glycol in the treatment of puerperal constipation. G E N 1995, 49:224-226.
219. Rimensberger P., Schubiger G., Willi U. Connatal rickets following repeated administration of phosphate enemas in pregnancy: a case report. Eur J Pediatr 1992, 151:54-56.
220. Schwethelm B., Margolis L.H., Miller C., Smith S. Risk status and pregnancy outcome among Medicaid recipients. Am J Prev Med 1989, 5:157-163.
221. Carrie L.E., O'Sullivan G.M., Seegobin R. Epidural fentanyl in labour. Anaesthesia 1981, 36:965-969.
222. Fernando R., Bonello E., Gill P., Urquhart J., Reynolds F., Morgan B. Neonatal welfare and placental transfer of fentanyl and bupivacaine during ambulatory combined spinal epidural analgesia for labour. Anaesthesia 1997, 52:517-524.
223. Lindemann R. Respiratory muscle rigidity in a preterm infant after use of fentanyl during Caesarean section. Eur J Pediatr 1998, 157:1012-1013.
224. Regan J., Chambers F., Gorman W., MacSullivan R. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG 2000, 107:570-572.
225. Briggs G., Freeman R., Yaffe S. Drugs in pregnancy and lactation 2005, Lippincott, Williams, Wilkins.
226. Nitsun M., Szokol J.W., Saleh H.J., Murphy G.S., Vender J.S., Luong L., et al. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther 2006, 79:549-557.
227. Matheson I., Lunde P.K., Bredesen J.E. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol 1990, 30:787-793.
228. Zelinkova Z., Mensink P.B., Dees J., Kuipers E.J., van der Woude C.J. Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases. Scand J Gastroenterol 2010, 45:483-489.